# Modernization of in vivo-in Vitro Oral Bioperformance Prediction and Assessment

> **NCT02806869** · NA · COMPLETED · sponsor: **University of Michigan** · enrollment: 48 (actual)

## Conditions studied

- Human Gastrointestinal Physiology Data

## Interventions

- **DRUG:** Single dose of ibuprofen (800 mg tablet)
- **DIETARY_SUPPLEMENT:** Pulmocare, two 8.0 oz (236.6 mL) cans

## Key facts

- **NCT ID:** NCT02806869
- **Lead sponsor:** University of Michigan
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-01
- **Primary completion:** 2016-11
- **Final completion:** 2017-07
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2017-12-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02806869

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02806869, "Modernization of in vivo-in Vitro Oral Bioperformance Prediction and Assessment". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02806869. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*